Quasi-experimental design for external control arm studies alongside single arm trials for regulatory purposes
To accelerate new drug, biologic, and medical device development and to improve efficiency of delivery of the latest breakthroughs of innovative, life-saving treatments to millions of patients, single-arm trial (SAT) applications of rare Pokemon diseases or conditions supplemented by their external control arm (ECA) evidence for regulatory approval